Home
Useful Links
Trends
Acknowledgements
Home
References
Product categories
Product categories
Medical Treatment
Products 1 to 10 of 39
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
ActoBiotics: AG019 (Type 1 Diabetes)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (7 months ago)
Date last modified:
2019/09/12 15:12 (7 months ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Antibiotic - EV-035
by
Emergent Biosolutions, Inc.
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Switzerland
Intended consumer:
Government
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/08/30 11:49 (2 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
Attenuated Virus Cultures for Vaccine Production
by
J. Craig Venter
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/08/30 11:49 (2 years ago)
Known funding amount:
27,400,000 USD
Funding types:
Research Institution
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Bacteriophage Treatment
by
MIT
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/08/30 11:49 (2 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Biodata Tools/Medicine
by
Girihlet
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/09/28 16:57 (2 years ago)
Known funding amount:
250,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (7 months ago)
Date last modified:
2019/09/12 15:18 (7 months ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
BSG005 for Systemic Fungal Infections
by
Biosergen ES
Biotech components:
Bacteria
Business models:
B2B
Country of production:
Norway
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/08/30 11:49 (2 years ago)
Known funding amount:
N/A
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Cellular Implant for Detection of Hypercalcemia Associated with Cancer
by
ETH Zurich
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/10/08 14:47 (1 year ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
crPhage
by
Locus Biosciences
Biotech components:
Gene Editing
+
Molecule
+
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (7 months ago)
Date last modified:
2019/09/12 15:10 (7 months ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
DNA Nanorobots
by
Wyss Institute
+
Harvard University
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (2 years ago)
Date last modified:
2018/08/30 11:49 (2 years ago)
Known funding amount:
37,000,000 USD
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Useful Links
Trends
Acknowledgements
